Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...

New Delhi, Jun 23 (PTI) India's biotechnology sector has expanded rapidly in the past decade, with its bioeconomy growing ...

India’s biotechnology sector has expanded rapidly in the past decade, with its bioeconomy growing from USD 35.5 billion in ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by 2035, representing a robust CAGR of 9.80%.Increasing prevalence of ...

India's biotechnology sector has grown fivefold in a decade, reaching USD 165.7 billion in 2024, driven by innovation and ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced the completion of initial patient screening in the ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional ...

Phase I part showed 100% Disease-Free Survival (DFS) after a minimum of 2-year follow-up - providing clinical proof of principle for TG4050 Randomization of all patients expected to be completed by en ...

TG4050, the first individualized therapeutic vaccine based on the myvac® platform ... The portfolio also includes other viral-vector-based immunotherapies: TG4001 for the treatment of HPV-positive ...

Oxford researchers have developed a single-shot malaria vaccine using programmable microcapsules that release booster doses ...

A well-known example is the vaccine against the human papillomavirus (HPV), a virus that can cause cervical cancer ... Engineered thermoswitch in the baculovirus expression vector system for ...

One of the most effective vaccines available was going to become more accessible—until RFK Jr. dismissed the CDC’s advisory ...